Clinical studies of the DP1 antagonist laropiprant in asthma and allergic rhinitis

Journal of Allergy and Clinical Immunology

Volumn 124, Issue 5, 2009, Pages

  Philip, George ^a   van Adelsberg, Janet ^a   Loeys, Thomas ^a   Liu, Nancy ^a   Wong, Peggy ^a   Lai, Eseng ^a   Dass, S Balachandra ^a   Reiss, Theodore F ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

airway disease; asthma susceptibility; montelukast; Prostaglandin D receptor gene promoter

Indexed keywords

ALLERGEN; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CETIRIZINE; CORTICOSTEROID; LAROPIPRANT; MONTELUKAST; PLACEBO; PROSTAGLANDIN D2;

ADULT; AGED; ANGIONEUROTIC EDEMA; ARTICLE; ASTHMA; AUTUMN; BACKACHE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIPLOIDY; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG WITHDRAWAL; DYSPEPSIA; FEMALE; FORCED EXPIRATORY VOLUME; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC TRANSCRIPTION; GENETIC VARIABILITY; HAPLOTYPE; HAY FEVER; HUMAN; KIDNEY COLIC; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NEPHROLITHIASIS; PARALLEL DESIGN; PRIORITY JOURNAL; PROMOTER REGION; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SENSITIZATION; UPPER ABDOMINAL PAIN; UPPER RESPIRATORY TRACT INFECTION; URINARY TRACT INFECTION;

ACETATES; ADOLESCENT; ADULT; AGED; ANTI-ALLERGIC AGENTS; ANTI-ASTHMATIC AGENTS; ASTHMA; CETIRIZINE; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; INDOLES; MALE; MIDDLE AGED; PROMOTER REGIONS, GENETIC; QUINOLINES; RECEPTORS, PROSTAGLANDIN; RHINITIS, ALLERGIC, SEASONAL; YOUNG ADULT;

EID: 71749095907     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2009.07.006     Document Type: Article

References (25)

1. Global Initiative for Asthma. Global Strategy for asthma management and prevention (2006), National Institutes of Health, Bethesda NIH Publication No 02-3659
2. Bousquet J. Allergic rhinitis and its impact on asthma (ARIA). Clin Exp Allergy Rev 3 (2003) 43-45
3. Pettipher R., Hansel T.T., and Armer R. Antagonism of the prostaglandin D2 receptors DP1 and CRTH2 as an approach to treat allergic diseases. Nat Rev Drug Discov 6 (2007) 313-325
4. Kostenis E., and Ulven. Emerging roles of DP and CRTH2 in allergic inflammation. Trends Mol Med 12 (2006) 148-158
5. Matsuoka T., Hirata M., Tanaka H., Takahashi Y., Murata T., Kabashima K., et al. Prostaglandin D2 as a mediator of allergic asthma. Science 287 (2000) 2013-2017
6. Kabashima K., and Narumiya S. The DP receptor, allergic inflammation and asthma. Prostaglandins Leukot Essent Fatty Acids 69 (2003) 187-194
7. Arimura A., Yasui K., Kishino J., Asanuma F., Hasegawa H., Kakudo S., et al. Prevention of allergic inflammation by a novel prostaglandin receptor antagonist, S-5751. J Pharmacol Exp Ther 29 (2001) 411-419
8. Mansur A.H., Bishop D.T., Holgate S.T., Markham A.F., and Morrison J.F. Linkage/association study of a locus modulating total serum IgE on chromosome 14q13-24 in families with asthma. Thorax 59 (2004) 876-882
9. Oguma T., Palmer L.J., Birben E., Sonna L.A., Asano K., and Lilly C.M. Role of prostanoid DP receptor variants in susceptibility to asthma. N Engl J Med 351 (2004) 1752-1763
10. Cheng K., Wu T.-J., Wu K.K., Sturino C., Metters K., Gottesdiener K., et al. Antagonism of the prostaglandin D2 receptor 1 suppresses nicotinic acid-induced vasodilation in mice and humans. Proc Natl Acad Sci U S A 103 (2006) 6682-6687
11. Lai E., Wenning L.A., Crumley T.M., De Lepeleire I., Liu F., de Hoon J.N., et al. Pharmacokinetics, pharmacodynamics, and safety of a prostaglandin D2 receptor antagonist. Clin Pharmacol Ther 83 (2008) 840-847
12. Van Hecken A., Depre M., De Lepeleire I., Thach C., Oeyen M., Van Effen J., et al. The effect of MK-0524, a prostaglandin D(2) receptor antagonist, on prostaglandin D2-induced nasal airway obstruction in healthy volunteers. Eur J Clin Pharmacol 63 (2007) 135-141
13. Wei L. An efficient design for a study comparing two drugs, their combination and placebo. Stat Med 30 (2006) 2043-2058
14. Santanello N.C., Barber B.L., Reiss T.F., Friedman B.S., Juniper E.F., and Zhang J. Measurement characteristics of two asthma symptom diary scales for use in clinical trials. Eur Respir J 10 (1997) 646-651
15. Excoffier L., and Slatkin M. Maximum-likelihood estimation of molecular haplotype frequencies in a diploid population. Mol Biol Evol 12 (1995) 921-927
16. Philip G., Malmstrom K., Hampel F.C., Weinstein S.F., LaForce C.F., Ratner P.H., et al. Montelukast for treating seasonal allergic rhinitis: a randomized, double-blind, placebo-controlled trial performed in the spring. Clin Exp Allergy 32 (2002) 1020-1028
17. Van Adelsberg J., Philip G., Pedinoff A.J., Meltzer E.O., Ratner P.H., Menten J., et al. Montelukast improves symptoms of seasonal allergic rhinitis over a 4-week treatment period. Allergy 58 (2003) 1268-1276
18. Storms W. Update on montelukast and its role in the treatment of asthma, allergic rhinitis and exercise-induced bronchoconstriction. Exp Opin Pharmacother 8 (2007) 2173-2187
19. Malmstrom K., Rodriguez-Gomez G., Guerra J., Villaran C., Piñeiro A., Wei L.X., et al. Oral montelukast, inhaled beclomethasone, and placebo for chronic asthma. A randomized, controlled trial. Ann Intern Med 130 (1999) 487-495
20. Sanz C., Isidoro-Garcia M., Davila I., Moreno E., Laffond E., Avila C., et al. Promoter genetic variants of prostanoid DP receptor (PTGDR) gene in patients with asthma. Allergy 61 (2006) 543-548
21. Leung TF, Li CY, Kong APS, Chan IHS, Ng MCY, Chan MHM, et al. PTGDR is not a major candidate gene for asthma and atopy in Chinese children. Pediatr Allergy Immunol [Epub ahead of print].
22. Tsai Y.J., Choudhry S., Kho J., Beckman K., Tsai H., Navarro D., et al. The PTGDR gene is not associated with asthma in 3 ethnically diverse populations. J Allergy Clin Immunol 118 (2006) 1242-1248
23. Morita H., and Nagai R. Prostanoid DP receptor variants and asthma. N Engl J Med 352 (2005) 837-838
24. Okano M., Fujiwara T., Sugata Y., Gotoh D., Masaoka Y., Sogo M., et al. Presence and characterization of prostaglandin D2-related molecules in nasal mucosa of patients with allergic rhinitis. Am J Rhinol 20 (2006) 342-348
25. Nantel F., Fong C., Lamontagne S., Wright D.H., Giaid A., Desrosiers M., et al. Expression of prostaglandin D synthase and the prostaglandin D2 receptors DP and CRTH2 in human nasal mucosa. Prostaglandins Other Lipid Mediat 73 (2004) 87-101